Literature DB >> 6644886

Superficial bladder cancer: progression and recurrence.

N M Heney, S Ahmed, M J Flanagan, W Frable, M P Corder, M D Hafermann, I R Hawkins.   

Abstract

The tumors in 249 patients presenting initially with stages Ta and T1 bladder cancer were analyzed for tumor progression and recurrence. Only transurethral resection and/or fulguration was used before the first recurrence. Patients who received intravesical chemotherapy after the first tumor recurrence were excluded from an analysis of progression. Progression according to stages Ta and T1, and grades I, II and III was 4, 30, 2, 11 and 45 per cent, respectively. All differences were statistically significant. Progression also correlated with nontumor dysplasia and size. High tumor grade, lamina propria invasion, atypia elsewhere in the bladder, positive urinary cytology, tumor multiplicity and large tumors were associated with shorter intervals free of disease.

Entities:  

Mesh:

Year:  1983        PMID: 6644886     DOI: 10.1016/s0022-5347(17)51695-x

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  101 in total

Review 1.  Biomarkers as surrogates for cancer development.

Authors:  E Hawk; J L Viner; J A Lawrence
Journal:  Curr Oncol Rep       Date:  2000-05       Impact factor: 5.075

Review 2.  Defining and treating the spectrum of intermediate risk nonmuscle invasive bladder cancer.

Authors:  Ashish M Kamat; J Alfred Witjes; Maurizio Brausi; Mark Soloway; Donald Lamm; Raj Persad; Roger Buckley; Andreas Böhle; Marc Colombel; Joan Palou
Journal:  J Urol       Date:  2014-03-25       Impact factor: 7.450

Review 3.  Early bladder cancer: concept, diagnosis, and management.

Authors:  Hiroshi Kitamura; Taiji Tsukamoto
Journal:  Int J Clin Oncol       Date:  2006-02       Impact factor: 3.402

Review 4.  Considerations on the use of diagnostic markers in management of patients with bladder cancer.

Authors:  Piyush K Agarwal; Peter C Black; Ashish M Kamat
Journal:  World J Urol       Date:  2007-12-19       Impact factor: 4.226

5.  Selecting patients for immediate cystectomy.

Authors:  Shahrokh F Shariat
Journal:  Rev Urol       Date:  2007

6.  The optimal management of T1 high-grade bladder cancer.

Authors:  Kenneth G Nepple; Michael A O'Donnell
Journal:  Can Urol Assoc J       Date:  2009-12       Impact factor: 1.862

Review 7.  New therapies for non-muscle-invasive bladder cancer.

Authors:  Edmund Chiong; Kesavan Esuvaranathan
Journal:  World J Urol       Date:  2009-09-18       Impact factor: 4.226

8.  P27(Kip1) and Ki-67 expression analysis in transitional cell carcinoma of the bladder.

Authors:  Bartosz Dybowski; Jolanta Kupryjańczyk; Alina Rembiszewska; Roman Pykało; Andrzej Borkowski
Journal:  Urol Res       Date:  2003-09-27

9.  Intravesical delivery of rapamycin suppresses tumorigenesis in a mouse model of progressive bladder cancer.

Authors:  Catherine M Seager; Anna M Puzio-Kuter; Trushar Patel; Shalini Jain; Carlos Cordon-Cardo; James Mc Kiernan; Cory Abate-Shen
Journal:  Cancer Prev Res (Phila)       Date:  2009-12-01

Review 10.  Superficial bladder carcinoma. Factors affecting the natural history.

Authors:  J M Fitzpatrick
Journal:  World J Urol       Date:  1993       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.